A groundbreaking study reveals that exercise can reduce cancer patients' risk of death by 37% and recurrence by 28%, proving it's even more effective than many drugs. This landmark trial could reshape health guidelines globally.
Starting late June, a groundbreaking blood test designed to diagnose Alzheimer’s disease will be available in the U.S., offering a faster and more cost-effective alternative to traditional methods. This innovation could revolutionize Alzheimer’s treatment and improve patient outcomes!
The FDA has approved the first blood test for Alzheimer's, allowing for earlier treatment with existing drugs. This innovative test measures protein ratios linked to the disease, promising better patient outcomes.
